Press release
Immunoassay Market Growth Driven by Rising Chronic Diseases and POC Testing | Top Companies are Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers AG.
Immunoassay Market
Immunoassays are bioanalytical techniques that utilize the specific binding between antigens and antibodies to detect and measure biological molecules. These methods have become indispensable in diagnostics, pharmaceutical research, and even food safety testing. Their high sensitivity, specificity, and adaptability to automation have positioned them as critical tools in modern healthcare systems. From detecting infectious diseases and chronic conditions to supporting personalized medicine, immunoassays are a cornerstone of the diagnostics landscape.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/immunoassay-market?nrk
According to DataM Intelligence, the global immunoassay market reached a value of US$ 36.87 billion in 2024 and is expected to grow to US$ 68.60 billion by 2033, reflecting a CAGR of 7.1% during the forecast period. This growth is driven by rising incidences of chronic and infectious diseases, growing demand for point-of-care testing, and technological advancements in assay platforms. Reagents and kits dominate the market due to their recurring demand, while North America maintains the largest regional share, supported by advanced healthcare infrastructure and significant R&D investments.
Key Highlights from the Report
➤ Market valued at US$ 36.87 billion in 2024, projected to reach US$ 68.60 billion by 2033.
➤ Reagents and kits segment leads the market due to frequent replacements.
➤ ELISA and chemiluminescent assays remain key technologies driving adoption.
➤ Hospitals and diagnostic laboratories represent the largest end-user segment.
➤ North America dominates global share, while Asia Pacific shows fastest growth.
➤ Strong demand for personalized medicine and biomarker testing fuels expansion.
Market Segmentation
The immunoassay market is structured around several core segments:
By Product Type: The largest share comes from reagents and kits, as these are essential for routine testing and must be replaced regularly. Instruments and analyzers follow, particularly as automation and digitalization continue to transform laboratory workflows.
By Technology: Key technologies include enzyme-linked immunosorbent assay (ELISA), chemiluminescent immunoassays (CLIA), radioimmunoassays, fluorescent immunoassays, and Western blotting. ELISA remains the gold standard due to reliability and cost-effectiveness, while CLIA is rapidly gaining adoption for its superior sensitivity and faster turnaround.
By Application: Immunoassays are widely used in detecting infectious diseases, oncology biomarkers, endocrinology disorders, cardiovascular conditions, and therapeutic drug monitoring. Infectious disease detection accounts for a large share of testing, but oncology is experiencing strong growth thanks to the rise of precision medicine.
By End-User: The primary consumers include hospitals and clinics, diagnostic laboratories, and pharmaceutical & biotechnology companies. Hospitals lead due to their large patient volumes and continuous need for fast and accurate testing, while biotech firms increasingly rely on immunoassays in drug development and clinical trials.
Regional Insights
North America is the leading region in the immunoassay market, driven by its advanced healthcare infrastructure, high prevalence of chronic diseases, and strong pipeline of technological innovations. The U.S. accounts for the largest national market, reflecting its sophisticated diagnostics network and strong presence of leading players.
Asia Pacific is projected to witness the fastest growth. Countries like China and India are expanding their healthcare systems and increasing investment in diagnostic technologies. The rising middle class, growing awareness of early disease detection, and the spread of infectious diseases also fuel adoption of immunoassays in this region.
Europe maintains a significant share, supported by high healthcare spending and government initiatives aimed at improving diagnostic accuracy. Meanwhile, Latin America and the Middle East & Africa are gradually expanding their market presence as infrastructure improves and awareness of advanced diagnostics grows.
Looking For A Detailed Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=immunoassay-market
Market Dynamics
Market Drivers
The global immunoassay market is primarily driven by the rising burden of chronic diseases such as cancer, diabetes, and cardiovascular conditions. Infectious diseases also contribute significantly, highlighting the critical role of accurate and rapid diagnostics. Technological innovations, including automation, multiplexing, and portable immunoassay platforms, further enhance efficiency and adoption. In addition, the growing use of immunoassays in drug discovery and monitoring therapeutic outcomes ensures their continued relevance.
Market Restraints
Despite strong growth prospects, challenges exist. High costs associated with advanced instruments and reagents may hinder adoption in low-resource settings. Regulatory complexities also present barriers, delaying product approvals and limiting market access. In addition, competition among players often leads to pricing pressure, particularly in commodity reagent markets.
Market Opportunities
The expansion of point-of-care testing represents a major opportunity, particularly in remote areas with limited access to central laboratories. The rise of personalized medicine and the need for biomarker-based testing further broaden the scope of immunoassays. Emerging economies offer untapped potential, with governments investing in modernizing diagnostic infrastructure. Advances in microfluidics and multiplex assays also create opportunities for faster, more comprehensive testing.
Frequently Asked Questions (FAQs)
◆ How big is the Immunoassay Market?
◆ What is the projected growth rate (CAGR) of the Immunoassay Market?
◆ Which region is expected to dominate the Immunoassay Market?
◆ What are the leading segments in the Immunoassay Market?
◆ What opportunities are driving future growth in the Immunoassay Market?
Company Insights
Key Players Operating in the Market:
• Abbott Laboratories
• Siemens Healthineers
• F. Hoffmann-La Roche Ltd
• Ortho Clinical Diagnostics
• Agilent Technologies
• DiaSorin
• Beckman Coulter Inc
• Merck KGaA
• bioMérieux SA
• Sysmex Corporation
Recent Developments:
In July 2023, Siemens Healthineers launched the Atellica CI Analyzer, an integrated system enhancing clinical chemistry and immunoassay testing efficiency.
In 2021, PerkinElmer acquired Immunodiagnostic Systems (IDS), strengthening its portfolio in chemiluminescent immunodiagnostics, particularly for endocrinology and infectious disease testing.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/immunoassay-market
Conclusion
The immunoassay market is on a strong growth trajectory, supported by technological innovation, rising healthcare needs, and the global push toward personalized medicine. While North America leads in terms of market share, Asia Pacific is rapidly emerging as the fastest-growing region. The dominance of reagents and kits highlights the recurring nature of demand, while automation and point-of-care testing represent the next wave of industry evolution. With opportunities expanding across multiple healthcare and industrial applications, the immunoassay market is set to play an increasingly vital role in shaping the future of diagnostics and biomedical research.
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immunoassay Market Growth Driven by Rising Chronic Diseases and POC Testing | Top Companies are Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers AG. here
News-ID: 4153737 • Views: …
More Releases from DataM Intelligence 4market Research LLP
Pregnancy Point of Care Testing Market to Hit US$ 3.84 billion by 2031, Report b …
Overview of the Market
The pregnancy point of care (POC) testing market has become one of the fastest-growing segments within the in-vitro diagnostics industry, driven by the increasing demand for quick, accurate, and convenient pregnancy detection methods. These tests, which can be performed at home or in clinical settings without the need for complex laboratory infrastructure, are transforming the way women access and monitor their reproductive health. Rapid results, cost-effectiveness, and…
Future of Biochemistry Analysers Market (2025 - 2033): Automation, AI, and Point …
Overview of the Market
Biochemistry analysers - sophisticated instruments used to measure enzymes, electrolytes, proteins, and metabolites in blood and body fluids play a pivotal role in modern diagnostics. These systems are crucial for disease detection, monitoring patient health, and guiding clinical decisions. Growing demand for rapid, accurate, and high-throughput diagnostic testing continues to fuel adoption across hospitals, laboratories, and research institutions.
Get a Sample PDF Brochure of the Report (Use Corporate…
Global Operating Procedure Tables Market (2024-2031): Growing at 4.3% CAGR to Re …
☛ Overview of the Market
The global operating procedure tables market has become a vital part of modern healthcare infrastructure, supporting surgical workflows across specialties such as orthopedics, gynecology, neurosurgery, and general surgery. These tables, designed to provide flexibility, stability, and comfort, are indispensable in facilitating minimally invasive procedures and advanced surgical techniques. With the rising prevalence of chronic diseases and the increasing demand for surgical interventions, operating procedure tables are…
Gene Therapy Market to Hit USD 35.9 Billion by 2033, Driven by CRISPR Advancemen …
Overview of the Market
The global gene therapy market is witnessing unprecedented growth, driven by rapid scientific advancements and a surge in demand for targeted, curative treatments. In 2024, the market was valued at approximately USD 4.80 billion, and it is projected to reach nearly USD 35.91 billion by 2033, expanding at a remarkable CAGR of 23.1%. This expansion reflects the increasing adoption of gene therapies in addressing rare genetic disorders,…
More Releases for Immunoassay
Prominent Chemiluminescence Immunoassay Analyzer Market Trend for 2025: Innovati …
What combination of drivers is leading to accelerated growth in the chemiluminescence immunoassay analyzer market?
The increasing incidence of chronic illnesses is predicted to spur the expansion of the chemiluminescence immunoassay analyzer market. Factors like aging populations, unhealthy lifestyles, and advancements in healthcare which prolong the lifespan of individuals with severe conditions, contribute to the rise in chronic diseases. Chemiluminescence immunoassay analyzers play a crucial role in managing chronic illnesses by…
Global Bench-top Automated Immunoassay Analyzer Market Size - By Product Type(Ch …
Bench-top Automated Immunoassay Analyzer Market Insights: Trends, Drivers, and Outlook 2024 - 2031
Bench-top Automated Immunoassay Analyzer Market Scope: Unveiling Today's Trends
A Bench-top Automated Immunoassay Analyzer is a compact device used for conducting immunoassays in laboratory settings, enhancing efficiency and accuracy. The market for these analyzers is experiencing significant growth driven by rising demand for rapid diagnostic testing and advancements in technology. Increased prevalence of conditions such as infectious diseases and…
Immunoassay Market - Advancing Patient Care through Immunoassay Solutions
Newark, New Castle, USA: The "Immunoassay Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Immunoassay Market: https://www.growthplusreports.com/report/immunoassay-market/8429
This latest report researches the industry structure, sales, revenue, price and…
Bahrain Immunoassay Analyzer Market
Transparent healthcare framework & strict procurement system enables the authorities in gaining the trust of the end-users leading to the growth of the medical devices industry in Bahrain: Ken Research
Heavy Government involvement in the industry: Bahrain has been maintaining a basic framework for a transparent, rules-based government procurement system. Bahrain hospitals and clinics, as well as developing specialist treatments, are continuously growing. This has improved the installation of BGA, POC…
Immunoassay Market Competitive Dynamics 2027
According to the new research report published by The Insight Partners, titled "Immunoassay Market- Global Analysis and Forecast to 2027".
The global immunoassay market is US$ 21,800.0 Mn in 2018 and is predicted to grow at a CAGR of 6.5% during the forecast period 2019 - 2027, to reach US$ 37,987.8 Mn by 2027.
Immunoassay Market Report presents a competitive scenario of key Immunoassay Industry players with their market share, sales, revenue…
Immunoassay Market: Opportunities and Challenges
The Immunoassay Market is expected to reach 27.15 billion by 2023 from USD 20.19 billion in 2018, at a CAGR of 6.1% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436
Will the development of condition-specific biomarkers and tests create opportunities for growth for players in the immunoassay market?
Biomarkers have gained significant clinical value and interest in the medical industry, as they are very useful in the screening, diagnosis, and treatment of diseases.…
